Structure-activity relationships of 11 new congeners of the SMTP plasminogen modulator

Journal of Antibiotics

Volumn 63, Issue 10, 2010, Pages 589-593

  Hasegawa, Keiko ^a   Koide, Haruki ^a   Hu, Weimin ^a   Nishimura, Naoko ^a   Narasaki, Ritsuko ^a   Kitano, Yoshikazu ^a   Hasumi, Keiji ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Fibrinolysis; plasminogen modulator; structure activity relationships

Indexed keywords

ALIPHATIC CARBOXYLIC ACID; AMINO ACID; CARBOXYL GROUP; PLASMINOGEN ACTIVATOR; SULFONIC ACID DERIVATIVE;

AMINO ACID SUBSTITUTION; ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

BENZOPYRANS; HUMANS; PLASMINOGEN ACTIVATORS; PYRROLIDINONES; STACHYBOTRYS; STRUCTURE-ACTIVITY RELATIONSHIP;

STACHYBOTRYS MICROSPORA;

EID: 78049320830     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2010.101     Document Type: Article

References (24)

1. Rijken, D. C. & Lijnen, H. R. New insights into the molecular mechanisms of the fibrinolytic system. J. Thromb. Haemost. 7, 4-13 (2008).
2. Lund, L. R. et al. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J. 25, 2686-2697 (2006).
3. Danø, K. et al. Plasminogen activation and cancer. Thromb. Haemost. 93, 676-681 (2005).
4. Boyle, M. D. & Lottenberg, R. Plasminogen activation by invasive human pathogens. Thromb. Haemost. 77, 1-10 (1997).
5. Forsgren, M., Raden, B., Israelsson, M., Larsson, K. & Heden, L.-O. Molecular cloning and characterization of a full-length cDNA clone for human plasminogen. FEBS Lett. 213, 254-260 (1987).
6. Cockell, C. S., Marshall, J. M., Dawson, K. M., Cederholm-Williams, S. A. & Ponting, C. P. Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide. Biochem. J. 333, 99-105 (1998).
7. An, S. S., Carreño, C., Marti, D. N., Schaller, J., Alberico, F. & Llinas, M. Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles. Protein Sci. 7, 1960-1969 (1998).
8. Nesheim, M. E., Fredenburgh, J. C. & Larsen, G. R. The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant DFEIX with intact fibrin. J. Biol. Chem. 265, 21541-21548 (1990).
9. Hajjar, K. A. & Nacman, R. L. Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface. J. Clin. Invest. 82, 1769-1778 (1988).
10. Shinohara, C., Hasumi, K., Hatsumi, W. & Endo, A. Staplabin, a novel fungal triprenyl phenol which stimulates the binding of plasminogen to fibrin and U937 cells. J. Antibiot. 49, 961-966 (1996).
11. Kohyama, T., Hasumi, K., Hamanaka, A. & Endo, A. SMTP-1 and -2, novel analogs of staplabin produced by Stachybotrys microspora IFO30018. J. Antibiot. 50, 172-174 (1997).
12. Takayasu, R., Hasumi, K., Shinohara, C. & Endo, A. Enhancement of fibrin binding and activation of plasminogen by staplabin through induction of a conformational change in plasminogen. FEBS Lett. 418, 58-62 (1997).
13. Hasumi, K., Ohyama, S., Kohyama, T., Ohsaki, Y., Takayasu, R. & Endo, A. Isolation of SMTP-3, -4, -5 and -6, novel analogs of staplabin, and their effects on plasminogen activation and fibrinolysis. J. Antibiot. 51, 1059-1068 (1998).
14. Hu, W., Ohyama, S. & Hasumi, K. Activation of fibrinolysis by SMTP-7 and -8, novel staplabin analogs with a pseudosymmetric structure. J. Antibiot. 53, 241-247 (2000).
15. Hu, W., Kitano, Y. & Hasumi, K. SMTP-4D, -5D, -6D, -7D and -8D, a new series of the non-lysine-analog plasminogen modulators with a D-amino acid moiety. J. Antibiot. 56, 832-837 (2003).
16. Hasumi, K., Hasegawa, K. & Kitano, Y. Isolation and absolute configuration of SMTP-0, a simplest congener of the SMTP family nonlysine-analog plasminogen modulators. J. Antibiot. 60, 463-468 (2007).
17. Ohyama, S., Harada, T., Chikanishi, T., Miura, Y. & Hasumi, K. Nonlysine-analog plasminogen modulators promote autocatalytic generation of plasmin(ogen) fragments with angiostatin-like activity. Eur. J. Biochem. 271, 809-820 (2004).
18. Hasumi, K., Yamamichi, S. & Harada, T. Small molecule modulators of the zymogen activation in the fibrinolytic and coagulation systems. FEBS J. 277, 3675-3687 (2010).
19. Shibata, K, Hashimoto, T, Nobe, K, Hasumi, K & Honda, K A novel finding of a low-molecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of mice. N.-S. Arch. Pharmacol. 382, 245-253 (2010).
20. Hashimoto, T., Shibata, K., Nobe, K., Hasumi, K. & Honda, K. A novel embolic model of cerebral infarction and evaluation of SMTP-7, a novel fungal triprenyl phenol metabolite. J. Pharmacol. Sci. (doi:10.1254/jphs.10131FP) (2010).
21. Hu, W., Ohyama, S., Narasaki, R. & Hasumi, K. Selective production of staplabin and SMTPs in cultures of Stachybotrysmicrospora fed with precursor amines. J. Antibiot. 54, 962-966 (2001).
22. Tetko, I. V. & Poda, G. I. Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds. J. Med. Chem. 47, 5601-5604 (2004).
23. Pal, D. & Chakrabarti, P. Non-hydrogen bond interactions involving the methionine sulfur atom. J. Biomol. Struct. Dyn. 19, 115-128 (2001).
24. Chakrabarti, P. & Bhattacharyya, R. Geometry of nonbonded interactions involving planar groups in proteins. Prog. Biophys. Mol. Biol. 95, 83-137 (2007). (Pubitemid 47513187)